Join us on November 29th for #GivingTuesday, a global day dedicated to giving. Following the widely recognized shopping events Black Friday and Cyber Monday, this day of generosity reminds us to share our gifts with others in need during the holiday season.
We encourage you to participate in the #GivingTuesday movement by giving to Nevada Center for Biomedical Research (NVCBR) in support of local discovery with a global impact. Your generous partnership on #GivingTuesday will help fund our efforts to find answers for millions who suffer from chronic complex neuro-inflammatory diseases.
You can easily donate at http://bit.ly/2fWtpbH or call 775-682-8250 for other donation options.
We’re proud to announce that Nevada Center for Biomedical Research will be well represented at the 12th International IACFS/ME Research and Clinical Conference: Emerging Science and Clinical Care in Ft. Lauderdale, FL, from October 27-30, 2016. Dr. Vincent Lombardi, NVCBR Research Director, Dr. Kenny De Meirleir, NVCBR Medical Director, and Annette Whittemore, NVCBR CEO, will attend the biannual conference, as well as the pre-conference at Nova Southeastern University. Drs. De Meirleir and Lombardi will be providing their unique insights into the diagnosis and scientific knowledge of myalgic encephalomyelitis or ME, the International Consensus Committee’s recommended name for this disease. Dr. De Meirleir will be sharing his most current diagnostic protocol, which includes the use of several biomedical tests, to identify those with ME. In addition, Dr. Lombardi will be providing key evidence for the use of a novel set of peptides as biomarkers that can quickly and accurately identify ME patients. This exciting work, which may provide the first specific biomedical biomarker for this disease, as well as direction for future pharmaceutical developments, was recently completed by NVCBR researchers in collaboration with scientists at Arizona State University and the University of Nevada, Reno.
Dr. Lombardi presented at the 2016 American Association of Immunologists annual meeting in Seattle, Washington. Dr. Lombardi presented data supporting a model of gut pathology in ME/CFS whereby dysregulated pDCs fail to promote the production of low-affinity IgA through the process of TI activation of B cells, thereby leading to bacterial overgrowth, dysbiosis, bacterial translocation and systemic immune activation.
champagne • wine • art • music
August 19, 2016
6:00 pm to 9:00 pm
The Nevada Museum of Art
Join Nevada Center for Biomedical Research (NVCBR) in support of scientific discovery and treat yourself to an entertaining evening at the Nevada Museum of Art!
Indulge in delectable bites created by tastemaker Mark Estee of Chez Louie while enjoying delicious champagne and wine. Between tastings, browse museum exhibits including Tilting the Basin: Contemporary Art of Nevada and Anthony McCall’s Drawn Together, a silent auction, and select local venders. Live music will be provided by The Socks, a Reno-based instrumental duo specializing in unplugged versions of great alternative rock hits, as well as their own unique original songs.
Buy your tickets in advance and save!
NVCBR collaborators find disturbed immune function in those with autism spectrum disorder (ASD), consistent with a growing body of evidence supporting immunopathology in ASD.
Decreased Numbers of CD57+CD3− Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder
NVCBR collaborative study finds genetic differences associated with core ME/CFS symptoms including poor immunity and infection control and disordered sleep. To the best of our knowledge, this study represents the most comprehensive genome-wide association study (GWAS) of an ME/CFS cohort conducted to date.
Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome